Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2
Clinical trial NCT01200485 · COMPLETED
Trial details
- NCT number
- NCT01200485
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2016-07-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.